Abiopharma

News list

Woods-Keisling Sharon 🟢 acquired 26.3K shares (2 derivative) of Spok Holdings, Inc (SPOK) Transaction Date: Jan 02, 2026 | Filing ID: 002564

Full text

News bot Jan. 5, 2026, 10:43 p.m.
🔍 Woods-Keisling Sharon (Executive)

Company: Spok Holdings, Inc (SPOK)

Report Date: 2026-01-02
Transaction Summary:
- Total transactions: 2
- Derivative instruments: 2
- Holdings reported: 0
- Total shares acquired: 26,298
Detailed Transactions and Holdings:
- Acquired 13,149 shares of Restricted Stock Unit (Derivative)
  Date: 2026-01-02 | Code: A | equity_swap_involved: false | shares_owned_after: 55,269.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
- Acquired 13,149 shares of Restricted Stock Unit (Derivative)
  Date: 2026-01-02 | Code: A | equity_swap_involved: false | shares_owned_after: 68,418.00 | transaction_form_type: 4 | Footnotes: F2, F3, F3
Footnotes:
- F1: The Restricted Stock Units, which if not forfeited, will convert into shares of common stock if specified performance objectives of the Company set forth in the 2026 LTIP are achieved for the year ending December 31, 2028
- F2: Each Restricted Stock Units ("RSUs") represents a contingent right to receive one share of the issuer's Common Stock.
- F3: The Restricted Stock Units vest in three equal annual installments beginning December 31, 2026. Vested shares will be delivered to the reporting person for the fiscal years ending December 31, 2026, December 31, 2027 and December 31, 2028.